Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Biochem ; 48(13-14): 919-22, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26025772

ABSTRACT

OBJECTIVES: Laboratories determine the most appropriate approach for the collection and transport of urine specimens. We investigated the effect of a chlorhexidine-based preservative tube on sample stability, compared the results of refrigerated polystyrene tubes with no additives, and investigated the effect of temperature on the performance of preservative tubes. DESIGN AND METHODS: Fresh urine specimen (n=48) aliquots in BD Vacutainer® Plus Urinalysis Preservative Tubes and polystyrene tubes were analyzed on an Iris Diagnostics iQ200. Samples in polystyrene tubes were refrigerated for 4 and 8h. Four aliquots in preservative tubes were kept at room temperature for 4, 8, 24, and 72h, while two aliquots were kept on ice for 4 and 8h. RESULTS: There was good agreement for all chemistry and microscopy parameters with the exceptions of white blood cells (WBCs) at 24 and 72h and red blood cells (RBCs) at 72h. Preservative tubes on ice showed a significant decrease in concordance of WBCs and calcium oxalate (CaOx) parameters compared with the results at room temperature. Results of refrigerated polystyrene tubes showed good agreement with the exceptions of WBC clumps and amorphous crystal at 8h. CONCLUSIONS: A chlorhexidine-containing preservative tube seems advantageous for urine sample transport from outside healthcare services. A preservative tube offers comparable results with urine samples kept in a refrigerator for 4-8h for the majority of parameters. Keeping samples at room temperature is recommended when preservative tubes are used because ice produces a negative effect on WBCs and CaOx.


Subject(s)
Cryopreservation , Ice , Preservatives, Pharmaceutical/pharmacology , Specimen Handling/methods , Temperature , Urinalysis/methods , Humans , Refrigeration
2.
Urology ; 70(6): 1184-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18158043

ABSTRACT

OBJECTIVES: To evaluate in a prospective study the coexistence of testicular microlithiasis with various scrotal pathologies and the relationship with testicular tumors in symptomatic patients presenting with various scrotal complaints. METHODS: A total of 197 male patients of reproductive age who applied to our clinic between December 2004 and June 2005 with various scrotal complaints were included in the study. Patient complaints were of pain, swelling, smallness of the testes, and infertility. Patients were evaluated according to their medical history, scrotal ultrasonograms, tumor markers, and hormone profiles after physical examination. Independent t test and Fisher's exact test were used for statistical analysis. RESULTS: The mean (+/-SD) age of the 197 patients was 28.3 +/- 8.5 years. Pathologic findings were testicular tumors (1.8%), cryptorchidism (3.5%), varicoceles (75%), hydroceles (9.8%), epididymal cysts (9%), and atrophic testes (0.9%). Testicular tumors were found in 4 patients, and testicular microlithiasis was observed in 3 (75%) of these patients. Testicular microlithiasis ratios were determined as 25% in cryptorchidism, 6.5% in varicocele, 23% in hydrocele, 10% in epididymal cyst, and 50% in atrophic testes. The rate of testicular microlithiasis was significantly higher in patients with testicular tumors. The mean follow-up of patients was 19.5 months (range, 16 to 23 months), during which no new cancer case was detected. CONCLUSIONS: Testicular microlithiasis was more frequently observed in patients presenting with mass lesions and testicular tumors. Our findings suggest that symptomatic patients should be warned and kept aware of this issue, particularly if they have risk factors for testicular cancer.


Subject(s)
Lithiasis/complications , Scrotum , Testicular Diseases/complications , Testicular Neoplasms/diagnosis , Adult , Humans , Infertility, Male/complications , Male , Pain/complications , Testicular Diseases/pathology , Testicular Neoplasms/complications , Testicular Neoplasms/pathology
3.
Urology ; 70(1): 55-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17656208

ABSTRACT

OBJECTIVES: To investigate the effect on the oncologic outcomes of treatment with transurethral resection of patients with a solitary bladder tumor smaller than 3 cm with a superficial appearance and benign prostatic hyperplasia. METHODS: The follow-up data from 34 men (group 1) who had undergone transurethral bladder tumor resection alone and 31 men who had undergone both transurethral prostate resection and transurethral bladder tumor resection at the same operation (group 2) in our clinic from 1996 to 2004 were retrospectively examined. The groups were also compared with each other. The recurrence and progression rates, elapsed time to recurrence, and the recurrence rates in the bladder neck and prostatic urethra were determined and compared. Statistical analysis was performed using the Mann-Whitney U and chi-square tests. RESULTS: The patients were followed up for at least 12 months (mean 28.9, range 12 to 98). The average follow-up period for group 1 was 27.4 months (range 12 to 91) and was 30.5 months (range 12 to 98) for group 2. The recurrence and progression rates for groups 1 and 2 were 41.2% and 8.8% and 35.5% and 9.7%, respectively. Recurrence in the bladder neck and/or prostatic urethra developed in 1 patient in each group. No statistically significant differences were found between groups in terms of follow-up time, recurrence, progression, recurrence in the prostatic urethra and/or bladder neck, and elapsed time to recurrence. CONCLUSIONS: According to our results, transurethral prostate resection can be safely performed with transurethral bladder tumor resection simultaneously in selected patients with severe lower urinary tract symptoms and a superficial solitary tumor smaller than 3 cm.


Subject(s)
Prostatic Hyperplasia/surgery , Transurethral Resection of Prostate , Urinary Bladder Neoplasms/surgery , Adult , Aged , Follow-Up Studies , Humans , Male , Middle Aged , Prostatic Hyperplasia/complications , Retrospective Studies , Treatment Outcome , Urinary Bladder Neoplasms/complications , Urinary Bladder Neoplasms/pathology , Urologic Surgical Procedures/methods
4.
Urol Int ; 71(1): 22-5, 2003.
Article in English | MEDLINE | ID: mdl-12845255

ABSTRACT

INTRODUCTION: We studied the impact of diuresis forced by oral hydration or single-dose oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms. PATIENTS AND METHODS: A total of 58 patients with a mean age of 59 (range 41-77) years who presented with lower urinary tract symptoms were included in the study. The patients were grouped with respect to their International Prostate Symptom Scores as having mild, moderate, or severe symptoms. The prostatic volumes of the patients were calculated using transrectal ultrasound. Uroflowmetric measurements were performed on 3 consecutive days. On the 1st day, the test was performed without diuretic stimulation; on the 2nd day, oral hydration was applied, and on the 3rd day, the patients received 20 mg of furosemide orally. Voiding time, maximum flow rate, voided volume, and the time elapsed in minutes until voiding (waiting time) were recorded. RESULTS: Diuretic stimulation did not significantly alter the uroflowmetric parameters in each symptom group, but the waiting time was significantly reduced. Forced diuresis caused acute urinary retention in 5 of 20 (25%) severely symptomatic patients. CONCLUSIONS: Forced diuresis with oral hydration or oral administration of diuretics improves patient comfort and test applicability by shortening clinical waiting time and reducing the number of attempts to reach the sufficient urine volume for reliable measurements and can be applied safely for mild and moderately symptomatic patients. On the other hand, the risk of 25% of acute urinary retentions should be reconsidered, and the decision about diuretic stimuli should be made carefully by the clinician in severely symptomatic patients.


Subject(s)
Appointments and Schedules , Diuresis/drug effects , Diuretics/administration & dosage , Fluid Therapy/methods , Furosemide/administration & dosage , Urodynamics/drug effects , Administration, Oral , Adult , Aged , Diuretics/adverse effects , Fluid Therapy/adverse effects , Furosemide/adverse effects , Humans , Male , Middle Aged , Prostatic Hyperplasia/complications , Rheology/drug effects , Time Factors , Urinary Retention/etiology , Urination Disorders/diagnosis , Urination Disorders/etiology , Urine/physiology
5.
Urol Res ; 30(3): 178-84, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12111181

ABSTRACT

The aim of this study is to determine the early effects of partial outflow obstruction (POO) on the detrusor contractility of diabetic (DM) and non-diabetic rats. A total of 67 adult female Wistar rats with average weight of 214+/-3.1 g were randomized into five groups as control ( n=6), sham operated ( n=6), obstructed ( n=18), DM ( n=19), and DM with obstruction ( n=18). Intraperitoneal injection of 60 mg/kg streptozotocin was performed to achieve DM. Partial bladder neck obstruction was created surgically by ligating the urethra around a 3F feeding tube. Bladder strips were obtained and inspected on days 3, 7, and 14 of both the diabetic period and POO. Mean detrusor weights were measured and the maximal contractile responses to carbachol (Car), adenosine 5'-triphosphate (ATP), substance P (SP) and electrical field stimulation (EFS) of detrusor strips in all groups were studied in vitro. After 14 days of obstruction, no remarkable difference was observed between the maximal contractile responses to Car and SP of strips from obstructed-only (POO) and diabetic-obstructed (DM-POO) rats compared to the control group. The responses to EFS and ATP in the POO rats were significantly lower than the controls ( P<0.01, P<0.01, respectively). In the DM-POO group however, the responses were significantly better than the POO group, reaching almost similar levels with the controls. The contractile responses of DM-POO rats were higher than the POO group but lower than the DM group. Better contractile responses of the rats with DM-POO than POO group can be explained by the early enhancing effects of DM on detrusor contractility. In early DM+POO period, the negative effects of POO on detrusor muscle contractility is masked by diabetes mellitus.


Subject(s)
Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/physiopathology , Muscle Contraction , Urinary Bladder Neck Obstruction/complications , Urinary Bladder Neck Obstruction/physiopathology , Urinary Bladder/physiopathology , Adenosine Triphosphate/pharmacology , Animals , Carbachol/pharmacology , Electric Stimulation , Female , Muscle, Smooth/physiopathology , Rats , Substance P/pharmacology , Urinary Bladder/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...